The molecular basis of breast cancer pathological phenotypes-Reference-Cited by-同舟云学术

The molecular basis of breast cancer pathological phenotypes

Published:2016-12-29 Issue:3 Volume:241 Page:375-391
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Heng Yujing J¹²,Lester Susan C³,Tse Gary MK⁴,Factor Rachel E⁵,Allison Kimberly H⁶,Collins Laura C¹²,Chen Yunn-Yi⁷,Jensen Kristin C⁶⁸,Johnson Nicole B¹²,Jeong Jong Cheol¹²,Punjabi Rahi¹²,Shin Sandra J⁹,Singh Kamaljeet¹⁰,Krings Gregor⁷,Eberhard David A¹¹,Tan Puay Hoon¹²,Korski Konstanty¹³,Waldman Frederic M¹⁴,Gutman David A¹⁵,Sanders Melinda¹⁶,Reis-Filho Jorge S¹⁷,Flanagan Sydney R¹²,Gendoo Deena MA¹⁸¹⁹,Chen Gregory M¹⁸,Haibe-Kains Benjamin¹⁸¹⁹,Ciriello Giovanni²⁰,Hoadley Katherine A²¹,Perou Charles M¹¹²¹,Beck Andrew H¹²

Affiliation:

1. Cancer Research Institute, Beth Israel Deaconess Cancer Center; Boston MA USA

2. Department of Pathology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston MA USA

3. Department of Pathology, Harvard Medical School; Brigham and Women's Hospital; Boston MA USA

4. Department of Anatomical & Cellular Pathology; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin NT Hong Kong

5. Department of Pathology, School of Medicine, Huntsman Cancer Institute; University of Utah; Salt Lake City UT USA

6. Department of Pathology, School of Medicine, Stanford Medical Center; Stanford University; Stanford CA USA

7. Department of Pathology, School of Medicine; University of California; San Francisco CA USA

8. VA Palo Alto Healthcare System; Palo Alto CA USA

9. Department of Pathology & Laboratory Medicine; Weill Cornell Medical College; New York NY USA

10. Department of Pathology & Laboratory Medicine; Brown University; Providence RI USA

11. Department of Pathology & Laboratory Medicine, School of Medicine; University of North Carolina; Chapel Hill NC USA

12. Department of Pathology; Singapore General Hospital; Singapore

13. Department of Pathology; Greater Poland Cancer Centre; Poznan Poland

14. Department of Laboratory Medicine, School of Medicine; University of California; San Francisco CA USA

15. Department of Biomedical Informatics, School of Medicine; Emory University; Atlanta GA USA

16. Department of Pathology, Microbiology and Immunology; Vanderbilt University; Nashville TN USA

17. Department of Pathology, Memorial Sloan Kettering Cancer Center; New York NY USA

18. Princess Margaret Cancer Centre; University Health Network; Toronto ON Canada

19. Departments of Medical Biophysics and Computer Science; University of Toronto; Toronto ON Canada

20. Department of Medical Genetics; University of Lausanne; Lausanne Switzerland

21. Department of Genetics, School of Medicine; University of North Carolina; Chapel Hill NC USA

Funder

Klarman Family Foundation

National Cancer Institute of the National Institutes of Health

National Library of Medicine of the National Institutes of Health Career Development Award

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference121 articles.

1. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up;Elston;Histopathology,1991

2. The Nottingham prognostic index in primary breast cancer;Galea;Breast Cancer Res Treat,1992

3. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98;Loi;J Clin Oncol,2013

4. Breast cancer prognostic classification in the molecular era: the role of histological grade;Rakha;Breast Cancer Res,2010

5. Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib and trastuzumab: a secondary analysis of the NeoALTTO Trial;Salgado;JAMA Oncol,2015

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic Therapy;Cancer Research Communications;2024-01-24

2. Targeting systemic and gut microbial metabolism in ER+ breast cancer;Trends in Endocrinology & Metabolism;2024-01

3. Cross-linking breast tumor transcriptomic states and tissue histology;Cell Reports Medicine;2023-12

4. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity;EMBO Molecular Medicine;2023-10-30

5. A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency;Cell Death Discovery;2023-10-02